Lars Bauer

Goethe University Frankfurt — Germany

Medicine · Health Sciences

27h-index4.4kcitations95works0.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Spondyloarthritis Studies and Treatments(31), Parkinson's Disease Mechanisms and Treatments(30), Rheumatoid Arthritis Research and Therapies(27), Multiple Sclerosis Research Studies(18), Psoriasis: Treatment and Pathogenesis(17)

Publications94 total

Ultrasonographic evaluation of ulnar innervated muscles in ulnar neuropathy at the elbow
PM&R·2025Open Access
Smart Walking Aids with Sensor Technology for Gait Support and Health Monitoring: A Scoping Review
Technologies·2025Open Access
Serum Alpha-Linolenic Acid and Long-Term Multiple Sclerosis Activity and Progression
Neurology·2025· 1 citedOpen Access
MeMoir: A Software-Driven Covert Channel based on Memory Usage
arXiv (Cornell University)·2024Open Access
Long-term clinical outcomes of certolizumab pegol treatment in non-radiographic axial spondyloarthritis stratified by baseline MRI and CRP status
RMD Open·2024· 2 citedOpen Access
OA11 Maintained improvement in patient reported outcomes in early axial spondyloarthritis following certolizumab pegol dose reduction
Lara D. Veeken·2024
POS0683 AN EXPLORATORY ANALYSIS OF THE POTENTIAL DISCONNECT BETWEEN OBJECTIVE INFLAMMATORY RESPONSE AND CLINICAL RESPONSE FOLLOWING CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS
Annals of the Rheumatic Diseases·2023· 1 citedOpen Access
POS0679 COMPARISON OF ESTABLISHED AND NEW, PRELIMINARY PROPOSED ASAS CUT-OFFS FOR INFLAMMATORY MRI LESIONS IN THE SACROILIAC JOINTS OF AXIAL SPONDYLOARTHRITIS PATIENTS AND IMPLICATIONS FOR RECRUITMENT IN CLINICAL STUDIES
Annals of the Rheumatic Diseases·2023Open Access
Disease awareness and knowledge of stroke- and atrial fibrillation risk factors in cardiovascular patients
EP Europace·2023· 1 citedOpen Access
Certolizumab Pegol Treatment in Patients with Axial-Spondyloarthritis-Associated Acute Anterior Uveitis: a Narrative Review
Rheumatology and Therapy·2022· 7 citedOpen Access
Certolizumab Pegol Efficacy in Patients With <scp>Non‐Radiographic</scp> Axial Spondyloarthritis Stratified by Baseline <scp>MRI</scp> and <scp>C‐Reactive</scp> Protein Status: An Analysis From the <scp>C‐axSpAnd</scp> Study
ACR Open Rheumatology·2022· 7 citedOpen Access
Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study
RMD Open·2022· 8 citedOpen Access
Effectiveness and Safety of Certolizumab Pegol in Axial Spondyloarthritis in a Real-World Setting in Greece: A Sub-Analysis of the Prospective Non-Interventional CIMAX Cohort Study
Mediterranean Journal of Rheumatology·2022· 1 citedOpen Access
Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol
Arthritis Research & Therapy·2021· 22 citedOpen Access
POS0229 DISEASE ACTIVITY AND INFLAMMATION FOLLOWING WITHDRAWAL OF CERTOLIZUMAB PEGOL TREATMENT IN AXIAL SPONDYLOARTHRITIS PATIENTS WHO DID NOT EXPERIENCE FLARES DURING THE C-OPTIMISE STUDY
Annals of the Rheumatic Diseases·2021· 2 citedOpen Access
POS0896 PREDICTORS OF RESPONSE IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS RECEIVING CERTOLIZUMAB PEGOL IN THE C-AXSPAND STUDY
Annals of the Rheumatic Diseases·2021Open Access
POS0897 REDUCTION OF ANTERIOR UVEITIS FLARES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS DURING CERTOLIZUMAB PEGOL TREATMENT: 96-WEEK RESULTS FROM THE C-VIEW STUDY
Annals of the Rheumatic Diseases·2021
Reduction of anterior uveitis flares in patients with axial spondyloarthritis on certolizumab pegol treatment: final 2-year results from the multicenter phase IV C-VIEW study
Therapeutic Advances in Musculoskeletal Disease·2021· 22 citedOpen Access
EARLIER TREATMENT OF NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS WITH CERTOLIZUMAB PEGOL RESULTS IN IMPROVED CLINICAL AND PATIENT-REPORTED OUTCOMES
Anais do Congresso Brasileiro de Reumatologia 2020·2021· 2 citedOpen Access
REDUCTION OF ANTERIOR UVEITIS FLARES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS DURING CERTOLIZUMAB PEGOL TREATMENT: 96-WEEK RESULTS FROM THE C-VIEW STUDY
Anais do Congresso Brasileiro de Reumatologia 2020·2021Open Access
page 1 of 5Next →

Frequent Co-authors

Bengt Hoepken(13), Frederik Barkhof(12), Rupert Sandbrink(12), Ludwig Kappos(11), Christoph Pohl(11), Mahnaz Asgharnejad(11), Mark S. Freedman(10), Gilles Edan(10), Xavier Montalbán(9), Chris H. Polman(8), David H. Miller(7), Désirée van der Heijde(7), Martín Rudwaleit(7), Walter P. Maksymowych(6), Erwin Surmann(6), Hans‐Peter Hartung(5), Robert Landewé(5), Natasha de Peyrecave(5), Elisabeth Dohin(5), Atul Deodhar(5)